Kennedy Capital Management’s Surmodics SRDX Stock Holding History
Bought
Maintained
Sold
Other funds holding SRDX
BCM
SCM
TI
Kennedy Capital Management's SRDX Position: Q3 2024 in Review
Kennedy Capital Management sold out of Surmodics (SRDX) in Q3 2024, closing a stake of 173,840 shares — an estimated $7.31M sold.
Kennedy Capital Management first reported a position in SRDX in Q3 2014 and held it in 14 quarters. The position peaked at $9.19M in Q2 2023. 126 funds tracked by Wall St. Rank hold SRDX as of Q3 2024.
- Kennedy Capital Management reported no remaining Surmodics position as of Q3 2024 after selling out during the quarter.
- Kennedy Capital Management sold 173,840 Surmodics shares in Q3 2024, an estimated $7.31M.
- Kennedy Capital Management first reported a position in Surmodics in Q3 2014 and held it in 14 quarters.
- Kennedy Capital Management's Surmodics position peaked at $9.19M in Q2 2023.
- 126 funds tracked by Wall St. Rank held Surmodics as of Q3 2024.
Based on Kennedy Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.